This page may not work correctly in your current browser, Internet Explorer. We recommend changing to a more modern browser before viewing this page. We recommend Chrome, Firefox, Safari, or Edge.

Home Study: A Review of Voxelotor and Crizanlizumab in Sickle Cell Disease

12/30/2022 01:00 PM - 12/30/2025 12:00 AM ET

Category

NJPhA Home Study

Admission

$15.00

Location

Home Study

Description

Print this page
Tell a friend

Dues are not deductible for income tax purposes as a charitable contribution. Dues may be deductible as ordinary and necessary business expenses, subject to certain restrictions. NJPhA estimates that the nondeductible portion of the 2025 dues is 14%. Contributions to the NJPhA PAC are made voluntarily and they are not deductible for income tax purposes.

Privacy Statement | Terms of Service

Leaving this Page

You are about to be redirected to another portal to manage your Peer-to-Peer Fundraising pages. You can return to this portal at any time.

Do you want to continue?

Cancel

Continue